Building on the success of previous events, SMi’s Controlled Release Delivery conference returns for its 15th year in London on 21-22 March 2018.

As physicians and scientists continue to find strategies to assist in simplifying treatment schedules for patients, a pharma focus continues to move towards innovative controlled release technologies to improve drug transport to target.

Moreover, with the global oral controlled release drug delivery technology market expected to flourish in the next few years, now is the time to get ahead of the game by exploring and understanding innovations in oral-lipid based and abuse deterrent formulations, nanoparticles and nanotechnologies, taste-masking and controlled release approaches, 3D printed dosage forms and functional film coats.

Featuring presentations to analyse and evaluate latest advancements in drug delivery, this year’s event highlights include:

• Formulation of Controlled Release Delivery Technologies and improving the design of new controlled release delivery systems
• Innovative additions to Oral Controlled Release Delivery Technologies, to improve the pharmacokinetic-pharmacodynamic properties of the drug
• Latest regulation guidance and their implications for the pharmaceutical industry
• Clinical developments and lessons learnt during clinical trials, through case studies with top pharmaceutical companies

Featured speakers include senior decision makers and innovators from University of Strathclyde, GSK, Ipsen, PLIVA, SiTech Pharmabio, Grunenthal, Colorcon, Bial, Peptigel Design, University of Central Lancashire and more!

Visit www.controlledreleasedelivery.com/pharmajournalist to view the full list of speakers and their presentations.

EARLY BIRD : Book by 30 November to save £400. Book by 15 December to save £200. Book by 31^st January to save £100.